middl
east
respiratori
syndrom
coronaviru
merscov
member
coronavirida
famili
caus
pathogen
mer
character
high
fever
pneumonia
acut
respiratori
distress
syndrom
ard
well
extrapulmonari
manifest
current
approv
treatment
regimen
vaccin
mer
gener
recombin
nonvirul
newcastl
diseas
viru
ndv
lasota
strain
express
merscov
protein
design
rlamerss
evalu
immunogen
mice
bactrian
camel
result
reveal
rlamerss
show
similar
growth
properti
lasota
embryon
chicken
egg
anim
immun
studi
show
rlamerss
induc
merscov
neutral
antibodi
mice
camel
find
suggest
recombin
rlamerss
may
potenti
merscov
veterinari
vaccin
candid
camel
anim
affect
mer
middl
east
respiratori
syndrom
coronaviru
merscov
member
c
lineag
genu
beta
coronaviru
caus
high
fever
pneumonia
acut
respiratori
distress
syndrom
ard
well
extrapulmonari
manifest
includ
gastrointestin
symptom
lymphopenia
mer
case
urgent
need
develop
vaccin
specif
drug
target
epidem
merscov
modjarrad
et
al
zumla
et
al
newcastl
diseas
viru
ndv
belong
genu
avulaviru
paramyxovirida
famili
ndv
classifi
lentogen
nonvirul
mesogen
moder
virul
velogen
highli
virul
accord
pathogen
poultri
lentogen
strain
lasota
also
appli
vaccin
vector
target
human
anim
diseas
ge
et
al
ge
et
al
di
napoli
et
al
b
ndv
innat
advantag
potenti
vaccin
vector
follow
reason
firstli
ndv
antigen
distinct
mammalian
paramyxovirus
typic
caus
product
infect
mammal
secondli
preexist
immun
mammalian
paramyxovirus
interfer
replic
capac
ndv
addit
safeti
profil
ndv
confirm
mani
nonhuman
primat
well
human
bukreyev
et
al
bukreyev
collin
khattar
et
al
kortekaa
et
al
membraneanchor
structur
protein
merscov
spike
protein
mediat
viral
receptor
bind
entri
belouzard
et
al
millet
whittak
protein
primari
target
anticoronaviru
vaccin
design
zhao
et
al
studi
demonstr
protein
immunogen
induc
neutral
antibodi
play
crucial
role
anticov
infect
hofmann
et
al
enjuan
et
al
du
et
al
pascal
et
al
current
sever
merscov
candid
vaccin
dna
vaccin
muthumani
et
al
viru
like
particl
vlp
well
recombin
viral
vector
vaccin
note
recombin
viral
vector
mer
vaccin
modifi
vaccinia
ankara
song
et
al
adenoviru
kim
et
al
demostr
good
immunogen
provid
protect
mice
nonhuman
primat
nhp
camel
merscov
challeng
herein
gener
recombin
ndv
lasota
viru
express
merscov
protein
evalu
immunogen
mice
camel
cell
grown
dulbecco
minimum
essenti
medium
dmem
contain
fetal
bovin
serum
fb
ndv
vector
viru
rla
rescu
genom
cdna
ndv
lasota
vaccin
strain
previous
describ
ge
et
al
recombin
ndv
grown
titrat
specificpathogenfre
spf
embryon
chicken
egg
allanto
caviti
inocul
recombin
vesicular
stomat
viru
vsv
vector
viru
express
merscov
protein
enhanc
green
fluoresc
protein
egfp
design
use
determin
induct
neutral
antibodi
merscov
recombin
vsvvector
viru
gener
replac
g
gene
recombin
vsv
express
egfp
merscov
gene
describ
previous
li
et
al
liu
et
al
grown
titrat
vero
cell
modifi
vaccinia
ankara
express
rna
polymeras
kindli
provid
dr
bernard
moss
nation
institut
health
bethesda
md
usa
grown
titrat
primari
chicken
embryo
fibroblast
wyatt
et
al
virus
store
use
construct
fulllength
recombin
ndv
genom
cdna
merscov
genbank
access
gene
amplifi
pcr
synthes
cdna
invitrogen
shanghai
china
use
follow
primer
ndv
gene
end
gene
start
sequenc
underlin
optim
kozak
sequenc
ital
pmei
restrict
site
bold
introduc
gene
introduc
ndv
genom
cdna
uniqu
pmei
site
pm
intergen
region
result
plasmid
design
prlamerss
use
viru
rescu
follow
establish
protocol
describ
previous
ge
et
al
rescu
viru
design
rlamerss
presenc
gene
ndv
genom
confirm
sequenc
entir
viral
genom
protein
express
rlamerss
infect
cell
confirm
indirect
immunofluoresc
western
blot
assay
pathogen
rlamerss
poultri
determin
mean
death
time
mdt
intracerebr
pathogen
index
icpi
intraven
pathogen
index
ivpi
embryon
spf
chicken
egg
spf
chicken
accord
oie
manual
oie
assess
pathogen
recombin
virus
mice
group
sixweekold
femal
balbc
mice
vital
river
beij
china
intramuscularli
im
inject
eid
embryo
infecti
dose
rlamerss
rla
ml
dilut
allanto
fluid
intranas
inocul
eid
rlamerss
rla
ml
dilut
allanto
fluid
third
group
mice
im
inject
ml
inocul
ml
pb
mock
infect
control
mice
monitor
daili
sign
ill
weight
loss
death
mous
immun
sixweekold
femal
balbc
mice
vital
river
beij
china
im
vaccin
eid
rlamerss
ml
dilut
allanto
fluid
three
week
first
dose
mice
boost
vaccin
dose
via
rout
serolog
assay
week
first
dose
prime
second
dose
boost
mous
blood
sampl
collect
retroorbit
sinus
isofluran
inhal
anesthesia
camel
immun
carri
experiment
anim
center
colleg
veterinari
medicin
inner
mongolia
agricultur
univers
china
three
group
per
group
adult
bactrian
camel
provid
colleg
veterinari
medicin
inner
mongolia
agricultur
univers
immun
group
anim
im
immun
eid
rlamerss
ml
dilut
allanto
fluid
group
anim
immun
im
eid
rla
ml
dilut
allanto
fluid
group
anim
im
inject
ml
pb
three
week
first
dose
camel
boost
vaccin
dose
via
rout
serum
collect
vaccin
week
prime
indirect
immunofluoresc
assay
ifa
use
detect
protein
express
rlamerss
infect
cell
cell
plate
cover
slip
dish
infect
rla
rlamerss
multipl
infect
moi
h
postinfect
cell
fix
paraformaldehyd
phosphatebuff
salin
pb
min
room
temperatur
cell
block
pb
contain
wv
bovin
serum
albumin
bsa
room
temperatur
h
cell
incub
mous
anti
serum
chicken
antindv
serum
h
room
temperatur
cell
wash
time
pb
contain
tween
pbst
stain
fitcconjug
goat
antimous
antibodi
sigma
st
loui
mo
usa
tritcconjug
rabbit
antichicken
antibodi
sigma
st
loui
mo
usa
min
cell
nuclei
stain
dapi
final
wash
stain
cell
analyz
leica
tc
confoc
laser
microscop
leica
microsystem
wetzlar
germani
cell
infect
rla
rlamerss
moi
cell
collect
lyse
h
postinfect
cell
lysat
subject
sdspage
denatur
condit
transfer
polyvinyliden
difluorid
pvdf
membran
western
blot
assay
use
chicken
antindv
serum
mous
anti
serum
primari
antibodi
horseradish
peroxidas
hrp
conjug
rabbitantichicken
igg
goatantimous
igg
secondari
antibodi
respect
sigma
st
loui
mo
usa
band
visual
ecl
plu
western
blot
detect
reagent
ge
healthcar
life
scienc
pittsburgh
pa
usa
kodak
xray
film
merscov
proteinspecif
igg
measur
elisa
describ
previous
kong
et
al
briefli
cell
seed
onto
two
well
sixwel
plate
infect
h
postinfect
cell
pellet
collect
lyse
repeat
pipet
supernat
coat
elisa
plate
overnight
plate
wash
block
bsa
wv
room
temperatur
h
serial
dilut
serum
ad
elisa
plate
incub
room
temperatur
h
plate
wash
three
time
pbst
dilut
hrplabel
goat
antimous
igg
southern
biotech
birmingham
al
ad
incub
anoth
h
room
temperatur
plate
wash
time
pbst
visual
tmb
liquid
substrat
sigma
st
loui
mo
usa
ad
well
min
room
temperatur
mol
l
sulfur
acid
ad
stop
reaction
od
valu
determin
model
micropl
reader
biorad
usa
nm
standard
curv
gener
coat
serial
dilut
purifi
unlabel
mous
igg
southern
biotech
birmingham
al
known
concentr
linear
equat
built
base
standard
igg
concentr
od
valu
thu
concentr
mersspecif
igg
could
determin
accord
linear
equat
camelspecif
igg
protocol
elisa
elisa
mous
serum
differ
dilut
hrp
conjug
rabbit
anticamel
igg
antibodi
neoscientif
usa
use
secondari
antibodi
due
lack
purifi
camel
igg
gener
standard
curv
camel
sera
elisa
result
express
rel
use
fix
dilut
assess
merscov
specif
neutral
antibodi
serial
dilut
serum
heat
inactiv
min
use
mix
dmem
contain
tcid
incub
h
mixtur
ad
cell
quadrupl
well
plate
egfpexpress
cell
count
h
postinfect
fluoresc
microscop
neutral
titer
determin
reciproc
highest
dilut
serum
show
least
reduct
number
fluoresc
cell
compar
neg
control
recombin
ndv
lasota
viru
express
egfp
design
rlaegfp
use
determin
neutral
antibodi
vector
briefli
serial
dilut
serum
mix
medium
contain
eid
rlaegfp
h
incub
mixtur
ad
cell
monolay
quadrupl
well
plate
gfpexpress
cell
count
h
postinfect
fluoresc
microscop
neutral
titer
express
reciproc
highest
dilut
serum
show
least
reduct
number
fluoresc
cell
compar
neg
control
twoway
anova
bonferroni
multipl
comparison
test
use
statist
analysi
pvalu
twotail
consid
statist
signific
associ
probabl
less
recombin
genom
cdna
rlamerss
construct
insert
gene
merscov
p
gene
ndv
fig
result
recombin
viru
rlamerss
success
rescu
fulllength
genom
cdna
clone
describ
protein
express
confirm
western
blot
analysi
mous
anti
serum
fig
indirect
immunofluoresc
confirm
protein
express
infect
cell
shown
fig
c
noninfect
cell
mock
stain
either
mous
anti
serum
chicken
antindv
serum
infect
cell
stain
mous
anti
serum
stain
chicken
antindv
serum
contrast
rlamerss
infect
cell
stain
mous
anti
serum
chicken
antindv
serum
growth
properti
rla
rlamerss
egg
examin
next
shown
fig
rlamerss
reach
peak
titer
logeid
ml
h
postinocul
stabil
gene
within
rlamerss
assess
serial
passag
viru
spf
chicken
egg
repeat
passag
passag
express
gene
assess
rtpcr
immunofluoresc
result
confirm
gene
stabli
maintain
express
data
shown
investig
whether
express
protein
alter
pathogen
ndv
vector
assess
pathogen
rlamerss
poultri
mice
accord
oie
manual
mdt
icpi
ivpi
test
use
assess
pathogen
ndv
strain
poultri
ndv
strain
classifi
three
group
base
mdt
velogen
h
mesogen
h
lentogen
h
result
show
mdt
rla
rlamerss
greater
h
indic
virus
lentogen
fig
rla
rlamerss
inocul
chicken
remain
healthi
observ
period
icpi
valu
rla
rlamerss
zero
respect
ivpi
valu
rla
rlamerss
zero
data
indic
rlamerss
rla
low
pathogen
spf
chicken
embryon
chicken
egg
suggest
insert
gene
ndv
increas
virul
ndv
vector
next
investig
safeti
recombin
virus
mammal
inocul
mice
im
eid
rla
rlamerss
ml
dilut
allanto
fluid
time
inocul
mice
eid
rla
rlamerss
ml
dilut
allanto
fluid
mice
observ
daili
two
week
sign
weight
chang
indic
ill
rla
rlamerss
infect
mice
show
similar
chang
bodi
weight
mockinfect
mice
sign
diseas
observ
anim
fig
mice
mersspecif
total
igg
level
determin
elisa
fig
notabl
total
igg
antibodi
level
significantli
boost
second
dose
p
furthermor
rlamerss
could
induc
fig
ii
antibodi
respons
fig
iii
second
dose
slightli
immun
mous
elisa
result
accord
result
ndv
mer
vna
assay
signific
ndv
vna
detect
mice
fig
merscov
vna
detect
blood
mice
inocul
rlamerss
rla
fig
second
dose
p
result
demonstr
rlamerss
highli
immunogen
mice
level
durat
recombin
virusinduc
neutral
antibodi
respons
shown
fig
camel
igg
protein
measur
elisa
primari
secondari
immun
fig
similar
elisa
antibodi
neutral
antibodi
boost
gradual
decreas
second
dose
rlamerss
immun
camel
merscov
neutral
antibodi
detect
second
dose
week
last
least
week
fig
signific
differ
week
level
neutral
antibodi
rlamerss
group
fig
ii
ndv
neutral
antibodi
detect
primari
immun
boost
second
dose
fig
izat
antibodi
titer
appar
rla
rlamerss
group
observ
period
merscov
deadli
emerg
infecti
pathogen
pose
seriou
public
health
threat
develop
merscov
vaccin
import
protect
suscept
anim
reduc
animaltohuman
transmiss
haagman
et
al
sabir
et
al
studi
recombin
ndv
rlamerss
express
merscov
protein
construct
rlamerss
maintain
high
growth
titer
embryon
egg
low
pathogen
poultri
mice
recombin
virus
induc
signific
merscovspecif
neutral
antibodi
mice
longlast
merscov
specif
neutral
antibodi
camel
find
demonstr
potenti
rlamerss
candid
veterinari
vaccin
merscov
infect
camel
merscovreservoir
anim
close
contact
human
may
facilit
human
infect
lead
sustain
outbreak
pandem
outbreak
perera
et
al
chu
et
al
merscov
reservoirharbor
capac
camel
draw
attent
date
estim
bactrian
camel
china
consequ
given
highli
threaten
zoonot
potenti
merscov
previous
carri
serolog
virolog
surveil
studi
camel
herd
west
inner
mongolia
autonom
region
china
although
studi
identifi
merscov
rna
antibodi
camel
herd
constant
vigil
still
requir
furthermor
result
underscor
necess
develop
reserv
vaccin
merscov
role
neutral
antibodi
protein
merscov
control
viral
infect
well
document
haagman
et
al
show
orthopoxvirusvector
merscov
vaccin
mva
effect
elicit
antibodi
merscov
could
significantli
reduc
amount
excret
infecti
viru
viral
rna
transcript
upon
merscov
challeng
addit
kim
et
al
report
recombin
adenovir
vector
encod
merscov
protein
could
induc
neutral
antibodi
mice
success
viralvector
merscov
vaccin
demonstr
protect
merscov
infect
camel
could
achiev
liveattenu
vectoredmerscov
vaccin
mvaor
adenovirusvector
mer
vaccin
safe
effect
product
process
complic
costli
thu
may
suitabl
use
develop
countri
contrast
ndvvector
vaccin
sever
advantag
safeti
efficaci
profil
confirm
mani
studi
easi
cultur
grown
high
titer
chicken
egg
requir
complic
cell
cultur
equip
thermost
lyophil
intranas
immun
present
studi
due
limit
camel
number
difficulti
practic
intranas
instil
camel
use
intranas
immun
consid
merscov
pathogen
respiratori
system
necessari
explor
compar
immunogen
rlamerscov
given
intranas
intramuscular
rout
studi
schedul
institut
larg
anim
facil
futur
present
studi
determin
immun
rlamerss
induc
slightli
higher
level
antibodi
protein
merscov
result
agreement
studi
zhang
et
al
author
demonstr
play
import
role
merscov
protect
transgen
mice
furthermor
observ
suggest
antibodi
respons
may
critic
inhibit
merscov
infect
howev
exclud
possibl
antibodi
may
play
domin
role
neutral
merscov
infect
result
demonstr
rlamerss
induc
compar
mer
neutral
antibodi
level
mva
may
indic
rlamerss
protect
due
unavail
merscov
imposs
us
perform
neutral
assay
use
live
merscov
instead
use
vsvbase
chimer
viru
mimic
merscov
serum
neutral
test
recombin
viru
use
protein
instead
g
protein
sole
membran
anchor
protein
attach
enter
cell
meanwhil
sinc
viru
engin
express
egfp
gene
addit
transcript
unit
posit
infect
cell
emit
green
fluoresc
result
show
replicationcompet
could
stabli
express
protein
egfp
protein
featur
render
reliabl
surrog
merscov
evalu
neutral
antibodi
capac
unavail
live
merscov
due
unavail
larg
anim
highcontain
facil
possibl
conduct
camel
challeng
studi
current
set
may
consid
futur
nevertheless
result
thu
demonstr
potenti
rlamerss
serv
candid
merscov
veterinari
vaccin
present
studi
demonstr
newcastl
diseas
virusvector
merscov
vaccin
rlamerss
elicit
highlevel
last
neutral
antibodi
mice
camel
rlamerss
could
potenti
merscov
veterinari
vaccin
candid
camel
anim
affect
merscov
